March 2020 Summaries

Rescale Inc., in partnership with Google Cloud and Microsoft Azure, has launched a program to provide free high-performance computing (HPC) resources to researchers working on COVID-19 vaccines and test kits. This initiative allows scientists to access powerful cloud-based HPC capabilities without the need for setup or IT teams, enabling faster simulation and collaboration across the globe. The program aims to expedite vaccine discovery and development by leveraging Rescale's platform, which integrates seamlessly with cloud resources from Google and Microsoft. Key figures from these companies emphasize the importance of speeding up research and eliminating barriers to access. Bionano Genomics is utilizing Rescale's platform to accelerate genome studies that could help identify genetic variations related to COVID-19 susceptibility. The availability of cloud HPC is set to revolutionize the way startups and enterprises develop new drugs by removing the necessity of on-premises supercomputers, thus allowing for scalable and customized processing. Rescale and its partners are committed to facilitating rapid scientific breakthroughs to combat the pandemic.

As the COVID-19 pandemic spread, the need for rapid research and development became critical, prompting a collaboration between Rescale, Google Cloud Platform, and Microsoft Azure to provide significant computing resources for COVID-19 research via cloud supercomputers. These high-performance computing resources enable global scientific collaboration and facilitate simulations, vaccine development, test kit creation, and genomic research to combat the virus. The initiative aims to streamline processes, reduce technical barriers, and eliminate cost limitations, thereby accelerating the development and deployment of solutions. Joris Poort, CEO of Rescale, emphasizes the importance of this effort, highlighting the role of cloud-based computational power in addressing the pandemic's challenges and the decisive action of tech leaders in supporting this global initiative.

Amid the COVID-19 pandemic, Rescale prioritizes the health and safety of its stakeholders while maintaining business operations through remote work and adherence to health guidelines. The company has launched the Tech Against Covid program in collaboration with Google Cloud Platform and Microsoft Azure, offering researchers access to its platform and donated compute credits to aid in developing testing methods, treatments, and vaccines. An internal response team is dedicated to deploying cloud HPC resources globally, accelerating efforts to combat the virus. Rescale also supports teams displaced by the pandemic by extending support coverage, offering accommodations, migrating workflows, and extending licenses. Joris Poort, Rescale's CEO, emphasizes the company's commitment to helping customers innovate and maintain productivity during these challenging times, inviting those working on COVID-19 projects to join their program.